Endpoints News 生物医药· Max Gelman·· 2026-09-30AI 评分45
#EADV26:Merck 公布 Prometheus 药物皮肤病适应症中期数据
#EADV26: Merck shows off mid-stage win for Prometheus drug in skin condition
AI 导读
Merck 在 EADV26 上公布其 108 亿美元收购 Prometheus Biosciences 核心药物在一种皮肤疾病中的中期数据。原文未披露具体药名、研究期别、样本量及疗效终点数值。
正文
Merck detailed some mid-stage data in a debilitating skin condition on Wednesday morning for the centerpiece of its $10.8 billion Prometheus Biosciences acquisition.
Both the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news